I think we just need time for the reality of the situation to sink and in flow through investment channels. Very very small unknown Aussie biotech holding such potential with very positive FDA guidance for COVID-19 all while holding pivotal HIV trials..... ticking all the boxes. If this was a US biotech value would easily be $300mill +. My expectation is price suppression while funding is finalised, but MM could have a few more tricks up her sleeve to come.
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-28
-
- There are more pages in this discussion • 445 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
